Literature DB >> 24872421

Regulated intramembrane proteolysis of the frontotemporal lobar degeneration risk factor, TMEM106B, by signal peptide peptidase-like 2a (SPPL2a).

Owen A Brady1, Xiaolai Zhou1, Fenghua Hu2.   

Abstract

The sequential processing of single pass transmembrane proteins via ectodomain shedding followed by intramembrane proteolysis is involved in a wide variety of signaling processes, as well as maintenance of membrane protein homeostasis. Here we report that the recently identified frontotemporal lobar degeneration risk factor TMEM106B undergoes regulated intramembrane proteolysis. We demonstrate that TMEM106B is readily processed to an N-terminal fragment containing the transmembrane and intracellular domains, and this processing is dependent on the activities of lysosomal proteases. The N-terminal fragment is further processed into a small, rapidly degraded intracellular domain. The GxGD aspartyl proteases SPPL2a and, to a lesser extent, SPPL2b are responsible for this intramembrane cleavage event. Additionally, the TMEM106B paralog TMEM106A is also lysosomally localized; however, it is not a specific substrate of SPPL2a or SPPL2b. Our data add to the growing list of proteins that undergo intramembrane proteolysis and may shed light on the regulation of the frontotemporal lobar degeneration risk factor TMEM106B.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Frontotemporal Lobar Degeneration; Intramembrane Proteolysis; Lysosomal Glycoprotein; Lysosome; Neurodegenerative Disease; SPPL2a; Shedding; TMEM106B

Mesh:

Substances:

Year:  2014        PMID: 24872421      PMCID: PMC4094077          DOI: 10.1074/jbc.M113.515700

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes.

Authors:  M K Lemberg; F A Bland; A Weihofen; V M Braud; B Martoglio
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

Review 2.  Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration.

Authors:  Dennis Selkoe; Raphael Kopan
Journal:  Annu Rev Neurosci       Date:  2003-04-18       Impact factor: 12.449

Review 3.  The ADAMs family of metalloproteases: multidomain proteins with multiple functions.

Authors:  Darren F Seals; Sara A Courtneidge
Journal:  Genes Dev       Date:  2003-01-01       Impact factor: 11.361

Review 4.  Gamma-secretase: proteasome of the membrane?

Authors:  Raphael Kopan; Ma Xenia G Ilagan
Journal:  Nat Rev Mol Cell Biol       Date:  2004-06       Impact factor: 94.444

5.  Inhibition of lysosomal protein degradation inhibits the basal degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Authors:  R D Tanaka; A C Li; A M Fogelman; P A Edwards
Journal:  J Lipid Res       Date:  1986-03       Impact factor: 5.922

6.  Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins.

Authors:  Elena Friedmann; Marius K Lemberg; Andreas Weihofen; Kumlesh K Dev; Uwe Dengler; Giorgio Rovelli; Bruno Martoglio
Journal:  J Biol Chem       Date:  2004-09-21       Impact factor: 5.157

7.  Identification of signal peptide peptidase, a presenilin-type aspartic protease.

Authors:  Andreas Weihofen; Kathleen Binns; Marius K Lemberg; Keith Ashman; Bruno Martoglio
Journal:  Science       Date:  2002-06-21       Impact factor: 47.728

8.  SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.

Authors:  X Wang; R Sato; M S Brown; X Hua; J L Goldstein
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

9.  A helix propensity scale based on experimental studies of peptides and proteins.

Authors:  C N Pace; J M Scholtz
Journal:  Biophys J       Date:  1998-07       Impact factor: 4.033

10.  Use of polyethyleneimine polymer in cell culture as attachment factor and lipofection enhancer.

Authors:  Ajith R Vancha; Suman Govindaraju; Kishore V L Parsa; Madhuri Jasti; Maribel González-García; Rafael P Ballestero
Journal:  BMC Biotechnol       Date:  2004-10-15       Impact factor: 2.563

View more
  14 in total

1.  A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelination.

Authors:  Tuancheng Feng; Rory R Sheng; Santiago Solé-Domènech; Mohammed Ullah; Xiaolai Zhou; Christina S Mendoza; Laura Camila Martinez Enriquez; Isabel Iscol Katz; Daniel H Paushter; Peter M Sullivan; Xiaochun Wu; Frederick R Maxfield; Fenghua Hu
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

2.  Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders.

Authors:  Julien Bryois; Daniela Calini; Will Macnair; Lynette Foo; Eduard Urich; Ward Ortmann; Victor Alejandro Iglesias; Suresh Selvaraj; Erik Nutma; Manuel Marzin; Sandra Amor; Anna Williams; Gonçalo Castelo-Branco; Vilas Menon; Philip De Jager; Dheeraj Malhotra
Journal:  Nat Neurosci       Date:  2022-08-01       Impact factor: 28.771

3.  Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43.

Authors:  Yi Xiao Jiang; Qin Cao; Michael R Sawaya; Romany Abskharon; Peng Ge; Michael DeTure; Dennis W Dickson; Janine Y Fu; Rachel R Ogorzalek Loo; Joseph A Loo; David S Eisenberg
Journal:  Nature       Date:  2022-03-28       Impact factor: 69.504

4.  Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.

Authors:  Andrew Chang; Xinyu Xiang; Jing Wang; Carolyn Lee; Tamta Arakhamia; Marija Simjanoska; Chi Wang; Yari Carlomagno; Guoan Zhang; Shikhar Dhingra; Manon Thierry; Jolien Perneel; Bavo Heeman; Lauren M Forgrave; Michael DeTure; Mari L DeMarco; Casey N Cook; Rosa Rademakers; Dennis W Dickson; Leonard Petrucelli; Michael H B Stowell; Ian R A Mackenzie; Anthony W P Fitzpatrick
Journal:  Cell       Date:  2022-03-04       Impact factor: 66.850

5.  The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death.

Authors:  Hiroaki Suzuki; Masaaki Matsuoka
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

Review 6.  What we know about TMEM106B in neurodegeneration.

Authors:  Alexandra M Nicholson; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2016-08-20       Impact factor: 17.088

Review 7.  Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Jessica Root; Paola Merino; Austin Nuckols; Michelle Johnson; Thomas Kukar
Journal:  Neurobiol Dis       Date:  2021-03-31       Impact factor: 7.046

8.  Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice.

Authors:  Xiaolai Zhou; Mieu Brooks; Peizhou Jiang; Shunsuke Koga; Aamir R Zuberi; Matthew C Baker; Tammee M Parsons; Monica Castanedes-Casey; Virginia Phillips; Ariston L Librero; Aishe Kurti; John D Fryer; Guojun Bu; Cathleen Lutz; Dennis W Dickson; Rosa Rademakers
Journal:  EMBO Rep       Date:  2020-08-05       Impact factor: 8.807

Review 9.  Physiological and pathological functions of TMEM106B: a gene associated with brain aging and multiple brain disorders.

Authors:  Tuancheng Feng; Alexander Lacrampe; Fenghua Hu
Journal:  Acta Neuropathol       Date:  2021-01-01       Impact factor: 17.088

10.  Systematic detection of functional proteoform groups from bottom-up proteomic datasets.

Authors:  Isabell Bludau; Max Frank; Christian Dörig; Yujia Cai; Moritz Heusel; George Rosenberger; Paola Picotti; Ben C Collins; Hannes Röst; Ruedi Aebersold
Journal:  Nat Commun       Date:  2021-06-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.